CAM – BIBA Medtech Insights

FDA 510(k) clearance for 14-Day Carnation Ambulatory Monitor patch

Bardy Diagnostics has received 510(k) clearance from the FDA for a 14-day version of the Carnation Ambulatory Monitor (CAM), which a press release says is market’s only P-wave centric ambulatory cardiac patch monitor and arrhythmia detection device. Developed to provide clinicians greater flexibility in cardiac monitoring over a longer period, the CAM patch will [...]

HealthTech Arkansas selects Bardy Diagnostics as one of six “disruptive medtech startups”

HealthTech Arkansas, a healthcare accelerator and investment fund that connects early-stage healthcare companies with disruptive technologies to Arkansas healthcare providers, has selected BardyDx to participate in its 2019 accelerator programme. BardyDx was chosen for its carnation ambulatory monitor (CAM)—the industry's only P-wave centric ambulatory cardiac patch monitor and arrhythmia detection device. HealthTech Arkansas is [...]